Biotech

Dynavax to Present at the William Blair 35th Annual Growth Stock Health Care Conference

BERKELEY, CA: ...

Ceapro Announces Election of Directors at 2015 Shareholders'' Meeting

EDMONTON, ALBERTA: ...

Dr. Sheila Singh, MD PhD. Joins Arch Biopartners as Medical and Clincial Advisor

TORONTO, ONTARIO: ...

Titan Pharmaceuticals Reports Positive Results From Phase 3 Study of Probuphine for Opioid Addiction

SOUTH SAN FRANCISCO, CA: New Drug Application Expected to Be Resubmitted in Second Half of 2015 Titan to Host Conference Call Today at 9 a.m. EDT ...

Titan Pharmaceuticals Schedules Conference Call to Review Results From Phase 3 Study of Probuphine for Opioid Addiction

SOUTH SAN FRANCISCO, CA: ...

Viking Therapeutics, Inc. Announces Chairman Appointment

SAN DIEGO, CA: ...

Prima BioMed to Maintain NASDAQ Listing

SYDNEY, AUSTRALIA: ...

InMed Adds Chronic Obstructive Pulmonary Disease (COPD) Program to Therapeutic Pipeline

VANCOUVER, BRITISH COLUMBIA: Initiates Discovery and Preclinical Work with Novel Cannabinoid-based Therapy ...

Spotlight Innovation Subsidiary Celtic Biotech Retains the FreeMind Group to Identify, Prepare, and File for Research and Development Grant Opportunities

WEST DES MOINES, IA: ...

New Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 American Society of Clinical Oncology Annual Meeting

SAN FRANCISCO, CA: ...